Study Enabling the Collection of Clinical Data Necessary for the Second Phase of Development of the Glycemic Measurement Device by Analysis of Exhaled Air

NARecruitingINTERVENTIONAL
Enrollment

235

Participants

Timeline

Start Date

October 11, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Type 2 Diabetes
Interventions
OTHER

Exhaled air analysis

The patient takes two breaths into two different Module In a Box devices (one measurement per device) which will give two measurements of the volatile organic compounds in the exhaled air. No estimate of blood glucose by breath will be displayed: the Module In Boxes will be set to only display the indication valid measurement/invalid measurement.

Trial Locations (2)

31059

RECRUITING

Rangueil Hospital, Toulouse

31 260

NOT_YET_RECRUITING

Fontaine Salée Hospital, Salies-du-Salat

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER